Journal of Dental Anesthesia and Pain Medicine

  • 제23권1호
  • /
  • Pages.19-28
  • /
  • 2023
  • /
  • 2383-9309(pISSN)
  • /
  • 2383-9317(eISSN)
대한치과마취과학회 (The Korean Dental Society of Anesthsiology)
권호 표지
DOI QR코드

DOI QR Code

Safety and efficacy of target controlled infusion administration of propofol and remifentanil for moderate sedation in non-hospital dental practice

  • 투고 : 2022.10.05
  • 심사 : 2022.12.27
  • 발행 : 2023.02.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Fearful and anxious patients who find dental treatment intolerable without sedative and analgesic support may benefit from moderate sedation. Target controlled infusion (TCI) pumps are superior to bolus injection in maintaining low plasma and effect-site concentration variability, resulting in stable, steady-state drug concentrations. We evaluated the safety and efficacy of moderate sedation with remifentanil and propofol using TCI pumps in non-hospital dental settings. Methods: A prospective chart review was conducted on 101 patients sedated with propofol and remifentanil using TCI pumps. The charts were completed at two oral surgeons and one general dentist's office over 6 months. Hypoxia, hypotension, bradycardia, and over-sedation were considered adverse events and were collected using Tracking and Reporting Outcomes of Procedural Sedation (TROOPS). Furthermore, patient recovery time, sedation length, drug dose, and patient satisfaction questionnaires were used to measure sedation effectiveness. Results: Of the 101 reviewed sedation charts, 54 were of men, and 47 were of women. The mean age of the patients was 40.5 ±18.7 years, and their mean BMI was 25.6 ± 4.4. The patients did not experience hypoxia, bradycardia, and hypotension during the 4694 min of sedation. The average minimum Mean Arterial Pressure (MAP) and heartbeats were 75.1 mmHg and 60.4 bpm, respectively. 98% of patients agreed that the sedation technique met their needs in reducing their anxiety, and 99% agreed that they were satisfied with the sedation 24 hours later. The average sedation time was 46.9 ± 55.6 min, and the average recovery time was 12.4 ± 4.4 min. Remifentanil and propofol had mean initial effect-site concentration doses of 0.96 µ/.ml and 1.0 ng/ml respectively. The overall total amount of drug administered was significantly higher in longer sedation procedures compared to shorter ones, while the infusion rate decreased as the procedural stimulus decreased. Conclusion: According to the results of this study, no patients experienced adverse events during sedation, and all patients were kept at a moderate sedation level for a wide range of sedation times and differing procedures. The results showed that TCI pumps are safe and effective for administering propofol and remifentanil for moderate sedation in dentistry.

키워드

과제정보

The Authors wish to thank Drs. Don Macalister and David Chrisp, oral surgeons in Auckland and Tauranga, and Dr. Graham Shaw, the general dentist in Auckland, New Zealand, who significantly contributed to this study, and sedations were performed in their offices. The researchers acknowledge the pioneering work of Dr. Don Macalister, who, over 20 years, modified and refined the medical TCI-TIVA (Total Intravenous Anesthesia) technique to a proven TCI-TIVS (Total Intravenous Sedation) technique appropriate for dentistry.

참고문헌

  1. American Society for Anesthesiologists (ASA). Continuum of depth of sedation: definition of general anesthesia and levels of sedation/analgesia. 2019, pp 1-2.
  2. Wiemer SJ, Nathan JM, Heggestad BT, Fillmore WJ, Viozzi CF, Van Ess JM, et al. Safety of outpatient procedural sedation administered by oral and maxillofacial surgeons: the mayo clinic experience in 17,634 sedations (2004 to 2019). J Oral Maxillofac Surg 2021; 79: 990-9. https://doi.org/10.1016/j.joms.2020.12.002
  3. Inverso G, Dodson TB, Gonzalez ML, Chuang SK. Complications of moderate sedation versus deep sedation/ general anesthesia for adolescent patients undergoing third molar extraction. J Oral Maxillofac Surg 2016; 74: 474-9. https://doi.org/10.1016/j.joms.2015.10.009
  4. Saiso K, Adnonla P, Munsil J, Apipan B, Rummasak D, Wongsirichat N. Complications associated with  intravenous midazolam and fentanyl sedation in patients undergoing minor oral surgery. J Dent Anesth Pain Med 2017; 17: 199-204. https://doi.org/10.17245/jdapm.2017.17.3.199
  5. G Cashion GT. What is the TCI dose required when using propofol for conscious sedation during dental procedures? : a retrospective study. Internet J Anesth 2014; 34: 1-5.
  6. Kapur A, Kapur V. Conscious sedation in dentistry. Ann Maxillofac Surg 2018; 8: 320-3. https://doi.org/10.4103/ams.ams_191_18
  7. Harbuz DK, O'Halloran M. Techniques to administer oral, inhalational, and iv sedation in dentistry. Australas Med J 2016; 9: 25-32. https://doi.org/10.4066/AMJ.2015.2543
  8. Canadian Agency for Drugs and Technologies in Health (CADTH). Moderate procedural sedation in adult patients: Guidelines 2016.
  9. Li Y, Picheca L. Target-controlled infusion with propofol and remifentanil for moderate procedural sedation in medicine and dentistry. Ottawa (ON). 2020.
  10. Nishizawa T, Suzuki H. Propofol for gastrointestinal endoscopy. United European Gastroenterol J 2018; 6: 801-5. https://doi.org/10.1177/2050640618767594
  11. Irwin MG, Wong GT, Lam SW. Taking on tiva. 1st ed. Cambridge, Cambridge University Press. 2020.
  12. Absalom AR, Mason KP. Total intravenous anesthesia and target controlled infusions. A comprehensive global anthology. Boston, Springer. 2017.
  13. Hu C, Horstman DJ, Shafer SL. Variability of target-controlled infusion is less than the variability after bolus injection. Anesthesiology 2005; 102: 639-45. https://doi.org/10.1097/00000542-200503000-00024
  14. Shin S, Kim S. Dental treatment in patients with severe gag reflex using propofol-remifentanil intravenous sedation. J Dent Anesth Pain Med 2017; 17: 65-9. https://doi.org/10.17245/jdapm.2017.17.1.65
  15. Mertens MJ, Olofsen E, Engbers FH, Burm AG, Bovill JG, Vuyk J. Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil-propofol interactions. Anesthesiology 2003; 99: 347-59. https://doi.org/10.1097/00000542-200308000-00016
  16. Nourbakhsh N, Kaviani N, Salari-Moghaddam R, Marzoughi S. Effects of remifentanil on the recovery quality among pediatric candidates for dental procedures under general anesthesia. Dent Res J 2022; 19: 15.
  17. Hirayama A, Fukuda KI, Koukita Y, Ichinohe T. Effects of the addition of low-dose ketamine to propofol anesthesia in the dental procedure for intellectually disabled patients. J Dent Anesth Pain Med 2019; 19: 151-8. https://doi.org/10.17245/jdapm.2019.19.3.151
  18. VanNatta ME, Rex DK. Propofol alone titrated to deep sedation versus propofol in combination with opioids and/or benzodiazepines and titrated to moderate sedation for colonoscopy. Am J Gastroenterol 2006; 101: 2209-17. https://doi.org/10.1111/j.1572-0241.2006.00760.x
  19. Kisilewicz M, Rosenberg H, Vaillancourt C. Remifentanil for procedural sedation: a systematic review of the literature. Emerg Med J 2017; 34: 294-301. https://doi.org/10.1136/emermed-2016-206129
  20. Wells DG, Verco S, Woods B, Savage J. Dental sedation: the advantages of propofol and remifentanil via target controlled infusions. Int J Dent Oral Health 2021; 7: 1-5. https://doi.org/10.18231/j.ijohd.2021.001
  21. Struys MM, De Smet T, Glen JI, Vereecke HE, Absalom AR, Schnider TW. The history of target-controlled infusion. Anesth Analg 2016; 122: 56-69. https://doi.org/10.1213/ANE.0000000000001008
  22. Roback MG, Green SM, Andolfatto G, Leroy PL, Mason KP. Tracking and reporting outcomes of procedural sedation (troops): standardized quality improvement and research tools from the international committee for the advancement of procedural sedation. Br J Anaesth 2018; 120: 164-72. https://doi.org/10.1016/j.bja.2017.08.004
  23. Barends CRM, Driesens MK, van Amsterdam K, Struys M, Absalom AR. Moderate-to-deep sedation using target-controlled infusions of propofol and remifentanil: adverse events and risk factors: a retrospective cohort study of 2937 procedures. Anesth Analg 2020; 131: 1173-83. https://doi.org/10.1213/ANE.0000000000004593
  24. Mitchell-Hines T, Ellison K, Willis S. Using bispectral index monitoring to gauge depth of sedation/analgesia. Nursing 2016; 46: 60-3. https://doi.org/10.1097/01.NURSE.0000476235.55728.9c
  25. Haberland CM, Baker S, Liu H. Bispectral index monitoring of sedation depth in pediatric dental patients. Anesth Prog 2011; 58: 66-72. https://doi.org/10.2344/0003-3006-58.2.66
  26. Gill M, Green SM, Krauss B. A study of the bispectral index monitor during procedural sedation and analgesia in the emergency department. Ann Emerg Med 2003; 41: 234-41. https://doi.org/10.1067/mem.2003.53
  27. Al-Rifai Z, Mulvey D. Principles of total intravenous anaesthesia: basic pharmacokinetics and model descriptions. BJA Education 2015; 16: 92-7. https://doi.org/10.1093/bjaceaccp/mkv021
  28. Al-Rifai Z, Mulvey D. Principles of total intravenous  anaesthesia: practical aspects of using total intravenous anaesthesia. BJA Education 2016; 16: 276-80. https://doi.org/10.1093/bjaed/mkv074
  29. Attri JP, Sharan R, Makkar V, Gupta KK, Khetarpal R, Kataria AP. Conscious sedation: emerging trends in pediatric dentistry. Anesth Essays Res 2017; 11: 277-81. https://doi.org/10.4103/0259-1162.171458
  30. Australian and New Zealand College of Anaesthetists (ANZCA). Guideline on procedural sedation. Australian and New Zealand College of Anaesthetists (ANZCA) 2022; 1-15.
  31. Clough S, Shehabi Z, Morgan C. Medical risk assessment in dentistry: use of the american society of anesthesiologists physical status classification. Br Dent J 2016; 220: 103-8. https://doi.org/10.1038/sj.bdj.2016.87
  32. Phillips W, Anderson A, Rosengreen M, Johnson J, Halpin J. Propofol versus propofol/ketamine for brief painful procedures in the emergency department: clinical and bispectral index scale comparison. J Pain Palliat Care Pharmacother 2010; 24: 349-55. https://doi.org/10.3109/15360288.2010.506503
  33. Weisenberg M, Sessler DI, Tavdi M, Gleb M, Ezri T, Dalton JE, et al. Dose-dependent hemodynamic effects of propofol induction following brotizolam premedication in hypertensive patients taking angiotensin-converting enzyme inhibitors. J Clin Anesth 2010; 22: 190-5. https://doi.org/10.1016/j.jclinane.2009.07.008
  34. Kramer KJ, Ganzberg S, Prior S, Rashid RG. Comparison of propofol-remifentanil versus propofol-ketamine deep sedation for third molar surgery. Anesth Prog 2012; 59: 107-17. https://doi.org/10.2344/12-00001.1
  35. Dixon C, Aspinall A, Rolfe S, Stevens C. Acceptability of intravenous propofol sedation for adolescent dental care. Eur Arch Paediatr Dent 2020; 21: 295-302. https://doi.org/10.1007/s40368-019-00482-0
  36. Pourabbas R, Ghahramani N, Sadighi M, Pournaghi Azar F, Ghojazadeh M. Effect of conscious sedation use on anxiety reduction, and patient and surgeon satisfaction in dental implant surgeries: a systematic review and meta-analysis. Dent Med Probl 2022; 59: 143-9. https://doi.org/10.17219/dmp/141868
  37. Wells DG, Verco S, Woods B, Paterson M. Intravenous conscious sedation for dental surgery: bolus alfentanil with propofol infusion enabling early recovery after surgery with fast track patient discharge. Int J Dent Oral Health 2020; 6: 1-7. https://doi.org/10.18231/j.ijohd.2020.001
  38. Lobb D, Ameli N, Ortiz S, Lai H. Comparison of the effects of target-controlled infusion-remifentanil/midazolam and manual fentanyl/midazolam administration on patient parameters in dental procedures. J Dent Anesth Pain Med 2022; 22: 117-28. https://doi.org/10.17245/jdapm.2022.22.2.117
  39. de Wit F, van Vliet AL, de Wilde RB, Jansen JR, Vuyk J, Aarts LP, et al. The effect of propofol on haemodynamics: cardiac output, venous return, mean systemic filling pressure, and vascular resistances. Br J Anaesth 2016; 116: 784-9. https://doi.org/10.1093/bja/aew126
  40. Ebert TJ. Sympathetic and hemodynamic effects of moderate and deep sedation with propofol in humans. Anesthesiology 2005; 103: 20-4. https://doi.org/10.1097/00000542-200507000-00007